Discussing Shifts in the Gene Editing Landscape to Transition from Ex Vivo to In Vivo Gene Editing
- Review the benefits of in vivo genome editing approaches from a patient perspective
- Explore the need to refocus the safety guidelines for in vivo treatments compared to ex vivo treatments
- Evaluate what approaches and strategies can be harnessed from ex vivo therapies to enhance in vivo therapy development